A brand-new look!
We are excited to announce that Julius Clinical has a brand-new look and website as part of the ongoing evolution of our company’s brand.
Why?
Ever since its foundation in 2008, Julius Clinical has been based on a unique triangle of scientific rigor, operational excellence, and strong site networks. While this remains the core of our company, we have grown and evolved over the past 15 years, and we came to realize that we have become so much more. This is symbolized by the hexagon in our new logo, that surrounds the well-known triangle.
When. Trials. Matter.
Over the past months, we analysed our organization’s values and created a brand identity that reflects those values. Our pay-off: “When.Trials.Matter.” reflects our endless commitment to supporting global clinical drug trials that will have a major impact on medicine and make a real difference to lives all around the world.
A big thank you
The rebranding has been a major process, involving many people from both inside and outside the organisation. We would like to express our appreciation to everyone who has contributed to this process. We could not have done it without you!
What’s next?
Over the coming weeks, the changes will become more and more visible. But for now, we would like to invite you to explore our brand-new website.
Related news
Julius Clinical welcomes Ricard Quingles Blasi as new Chief Business Officer
Zeist, Netherlands, April 5, 2024 — We’re proud to announce the appointment of Ricard Quingles Blasi as our new Chief Business Officer (CBO). With over 25 years of dynamic leadership experience, Ricard Quingles Blasi brings a wealth of strate...
Metabolic dysfunction associated steatotic liver disease and the heart
Commentary by Dr. Marco Alings, MD PhD, Amphia Ziekenhuis, Breda; WCN, Utrecht; Scientific Officer at Julius ClinicalThe estimated prevalence of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in the adult population is 31% ...
GRIPonMASH received significant EU funding to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH)
Utrecht, The Netherlands, 05-02-2024GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in the detection and treatment of Metabolic Dysfunc...